Physician profile
Rhett High
NPI 1528033826
$2,891.59
in general payments reported to CMS, 2019-2025
18 companies · $784 in 2025
The $784 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $51.47 · 2021: $411 · 2022: $518 · 2023: $318 · 2024: $481 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $570.35 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $466.03 | 2024-2025 | |
| Allergan, INC. | $355.20 | 2019-2022 | |
| Mentor Worldwide LLC | $331.45 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Lumenis Be INC | $250.00 | 2025 | M22 |
| Abbvie INC. | $239.47 | 2023-2025 | |
| Tela Bio, INC. | $223.24 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $134.80 | 2020-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Merz North America, INC. | $69.61 | 2021-2023 | |
| Tepha INC | $54.02 | 2019 | |
| Revance Therapeutics, INC. | $51.42 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $46.00 | 2021-2023 | |
| Rti Surgical, INC | $20.41 | 2023 | |
| Axogen | $19.97 | 2025 | |
| Medtronic, INC. | $15.88 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $15.67 | 2025 | Arista |
| Smith+Nephew, INC. | $14.92 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhett High listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.